- September 2, 2024Manchester, UK – 5. September 2024 – Das britische Pionierunternehmen Phagenesis, das ein neuartiges Neurostimulationssystem zur Behandlung von Schluckstörungen entwickelt…
- September 1, 2024MANCHESTER, England, Sept. 5, 2024 /PRNewswire/ — Phagenesis, a pioneering company that has developed a first-of-its-kind neurostimulation system to treat swallowing dysfunction, today…
- March 2, 2024Phagenesis, ein Medizintechnikunternehmen, das sich auf die Behandlung von Schluckstörungen spezialisiert hat, schließt erfolgreich eine Finanzierungsrunde der Serie D über…
- March 1, 2024Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round…
- August 1, 2023Hospital is one of the first three facilities in the country using the Phagenyx™ Neurostimulation System PHOENIX (Aug. 15, 2023)…
- May 2, 2023Augusta University Health’s Stroke Center was the first in Georgia to be designated as an Advanced Comprehensive Stroke Center a decade ago, and it is…
- May 1, 2023NEWS PROVIDED BY Gaylord Specialty Healthcare 09 May, 2023, 15:45 ET WALLINGFORD, Conn., May 9, 2023 /PRNewswire/ — Gaylord Specialty Healthcare, a nonprofit…
- October 1, 2022Phagenesis Launches Phagenyx Neurostimulation System in the U.S. NEWS PROVIDED BY Phagenesis, Ltd Oct 10, 2022, 02:00 ET MANCHESTER, England, Oct.…
- June 1, 2022MedTech Innovator Announces Top 50 Startups Selected for the 2022 Cohort in Tenth Year of World’s Largest MedTech Accelerator Program…
- April 1, 2021Manchester, England, 20 April 2021 – Phagenesis Ltd, a private healthcare company offering an innovative treatment for dysphagia, announces successful treatment…
